Your browser doesn't support javascript.
loading
Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial.
Rezvani, Hamid; Mortazavizadeh, Seyed Mohammadreza; Allahyari, Abolghasem; Nekuee, Amirabbas; Najafi, Safa Najjar; Vahidfar, Mohammadreza; Ghadyani, Mojtaba; Khosravi, Adnan; Qarib, Siroos; Sadeghi, Alireza; Esfandbod, Mohsen; Rajaeinejad, Mohsen; Rezvani, Alireza; Hajiqolami, Ali; Payandeh, Mehrdad; Shazad, Babak; Anjidani, Nassim; Meskinimood, Shahab; Alikhasi, Afsaneh; Karbalaeian, Moein; Salari, Sina.
Afiliação
  • Rezvani H; Department of Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mortazavizadeh SM; Department of Internal, Faculty of Medicine, Islamic Azad University, Yazd, Iran.
  • Allahyari A; Division of Hematology and Medical Oncology, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nekuee A; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Najafi SN; Tehran University of Medical Sciences, Tehran, Iran.
  • Vahidfar M; Yazd University of Medical Sciences, Yazd, Iran.
  • Ghadyani M; Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Khosravi A; Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Qarib S; Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
  • Sadeghi A; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Esfandbod M; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Rajaeinejad M; AJA University of Medical Sciences, Tehran, Iran.
  • Rezvani A; Shiraz University of Medical Sciences, Shiraz, Iran.
  • Hajiqolami A; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Payandeh M; Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Shazad B; Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Anjidani N; Head of Medical Department, OrchidPharmed Company, Tehran, Iran.
  • Meskinimood S; Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Alikhasi A; Department of Radiology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Karbalaeian M; Division of General Medicine of Medical School of Shaheed Sadoughi Medical School of Yazd University, Yazd, Iran.
  • Salari S; Department of Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: s.salari@sbmu.ac.ir.
Clin Ther ; 42(5): 848-859, 2020 05.
Article em En | MEDLINE | ID: mdl-32334845
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Medicamentos Biossimilares / Bevacizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Medicamentos Biossimilares / Bevacizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã